942920-55-0

Basic information

• Product Name: ethyl 4-bromo-1H-pyrrolo[2,3-b]pyridine-2-carboxylate
• Synonyms: ethyl 4-bromo-1H-pyrrolo[2,3-b]pyridine-2-carboxylate;3-b]pyridine-2-carboxylate;ethyl 4-broMo-1H-pyrrolo[2;ethyl 6-chloro-1H-pyrrolo[2;1H-Pyrrolo[2,3-b]pyridine-2-carboxylic acid, 4-broMo-, ethyl ester
• CAS NO: 942920-55-0
• Molecular Formula: C₁₀H₉BrN₂O₂
• Molecular Weight: 269.09
• Product Categories: CHIRAL CHEMICALS;Heterocycle-Pyridine series
• Mol File: 942920-55-0.mol

Chemical Properties

• Appearance: /
• Density: 1.624±0.06 g/cm3(Predicted)
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• PKA: 10.96±0.40(Predicted)
• CAS DataBase Reference: ethyl 4-bromo-1H-pyrrolo[2,3-b]pyridine-2-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: ethyl 4-bromo-1H-pyrrolo[2,3-b]pyridine-2-carboxylate(942920-55-0)
• EPA Substance Registry System: ethyl 4-bromo-1H-pyrrolo[2,3-b]pyridine-2-carboxylate(942920-55-0)

Safety Data

• Hazardous Substances Data: 942920-55-0(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
Ethyl 4-bromo-1H-pyrrolo[2,3-b]pyridine-2-carboxylate is used as a building block for the synthesis of various pharmaceutical products. Its unique structure and reactivity make it a valuable intermediate in the development of new drugs, particularly those targeting specific biological pathways or diseases.
Used in Agrochemical Industry:
In the agrochemical industry, ethyl 4-bromo-1H-pyrrolo[2,3-b]pyridine-2-carboxylate is utilized as a key intermediate in the synthesis of crop protection chemicals. Its chemical properties allow for the creation of effective compounds that can protect crops from pests and diseases, thereby enhancing agricultural productivity.
Used in Organic Synthesis:
Ethyl 4-bromo-1H-pyrrolo[2,3-b]pyridine-2-carboxylate is employed as a versatile intermediate in organic synthesis. Its bromine atom and ester functional group enable a wide range of chemical reactions, making it suitable for the preparation of various organic compounds with diverse applications.
Used in Biological Research:
Due to its potential biological activities, ethyl 4-bromo-1H-pyrrolo[2,3-b]pyridine-2-carboxylate is often studied for its pharmacological properties. Researchers investigate its interactions with biological systems to explore its potential as a therapeutic agent or to gain insights into its mechanism of action.

Upstream product

• 348640-06-2 4-bromo-7-azaindole 
• 889939-25-7 1-(benzenesulfonyl)-4-bromo-1H-pyrrolo[2,3-b]pyridine 
• 221675-35-0 1H-pyrrolo[2,3-b]pyridine-2-carboxylic acid ethyl ester 
• 287384-82-1 ethyl 1H-pyrrolo[2,3-b]pyridine-2-carboxylate-7-oxide 

Downstream Products

• 1234616-71-7 4-bromo-1H-pyrrolo[2,3-b]pyridine-2-carboxylic acid 
• 942920-54-9 4-[1-ethyl-3-(4-nitrophenyl)-1H-pyrazol-4-yl]-1H-pyrrolo[2,3-b]-pyridine-2-carboxylic acid 
• 945865-21-4 ethyl 4-(4,4,5,5-tetramethyl-1,3,2-diozaborolan-2-yl)-1H-pyrrolo[2,3-b]pyridine-2-carboxylate 
• 1021950-41-3 ethyl 4-[(4-nitrophenyl)amino]-1H-pyrrolo[2,3-b]pyridine-2-carboxylate 

Relevant articles and documents

DIHYDROISOQUINOLINE-2(1H)-CARBOXAMIDE AND RELATED COMPOUNDS AND THEIR USE IN TREATING MEDICAL CONDITIONS

The invention provides dihydroisoquinoline-2(1H)-carboxamide and related compounds, pharmaceutical compositions, and their use in the treatment of medical conditions, such as cancer, and in inhibiting HPK1 activity.

ARYL-BIPYRIDINE AMINE DERIVATIVES AS PHOSPHATIDYLINOSITOL PHOSPHATE KINASE INHIBITORS

The invention relates to inhibitors of PI5P4K inhibitors useful in the treatment of cancers, neurodegenerative diseases, inflammatory disorders, and metabolic diseases, having the Formula (I): wherein A, X, Y, Z, Q, R1, R2, R3, R4, R5, and n are described herein.

Discovery of GSK1070916, a potent and selective inhibitor of aurora B/C kinase

The Aurora kinases play critical roles in the regulation of mitosis and are frequently overexpressed or amplified in human tumors. Selective inhibitors may provide a new therapy for the treatment of tumors with Aurora kinase amplification. Herein we describe our lead optimization efforts within a 7-azaindole-based series culminating in the identification of GSK1070916 (17k). Key to the advancement of the series was the introduction of a 2-aryl group containing a basic amine onto the azaindole leading to significantly improved cellular activity. Compound 17k is a potent and selective ATP-competitive inhibitor of Aurora B and C with Ki* values of 0.38 ± 0.29 and 1.5 ± 0.4 nM, respectively, and is >250-fold selective over Aurora A. Biochemical characterization revealed that compound 17k has an extremely slow dissociation half-life from Aurora B (>480 min), distinguishing it from clinical compounds 1 and 2. In vitro treatment of A549 human lung cancer cells with compound 17k results in a potent antiproliferative effect (EC50 = 7 nM). Intraperitoneal administration of 17k in mice bearing human tumor xenografts leads to inhibition of histone H3 phosphorylation at serine 10 in human colon cancer (Colo205) and tumor regression in human leukemia (HL-60). Compound 17k is being progressed to human clinical trials.

Pyrrolo [2,3,B] Pyridine Derivatives Useful As RAF Kinase Inhibitors

The present invention provides pyrrolo pyridine compounds, compositions containing the same, as well as processes for the preparation and their use as pharmaceutical agents.

NOVEL COMPOUNDS

The present invention relates to compounds of formula (I): and processes for preparing them, compositions containing them and their use in treating diseases relating to inappropriate c-Met activity.

Knowledge-based design of 7-azaindoles as selective B-Raf inhibitors

The synthesis of a 7-azaindole series of novel, potent B-Raf kinase inhibitors using knowledge-based design was carried out. Compound 6h exhibits not only excellent potency in both the enzyme assay (IC50 = 2.5 nM) and the cellular assay (ICsub

INHIBITORS OF Akt ACTIVITY

Invented are novel thiophene compounds, the use of such compounds as inhibitors of protein kinase B activity and in the treatment of cancer and arthritis.